{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:03:19Z","timestamp":1785376999005,"version":"3.55.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bioorg.2020.104266","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:55:58Z","timestamp":1599080158000},"page":"104266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors"],"prefix":"10.1016","volume":"104","author":[{"given":"Shalini","family":"Jaswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupender","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-6241","authenticated-orcid":false,"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104266_b0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: A molecular perspective","volume":"6","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0010","first-page":"635","article-title":"DNA topoisomerases, Annual Review","volume":"65","author":"Wang","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104266_b0015","first-page":"873","article-title":"Analysis of Eukaryotic DNA Topoisomerases and Topoisomerase-Directed Drug Effects","volume":"34","author":"Boege","year":"1996","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bioorg.2020.104266_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/365227a0","article-title":"DNA topoisomerase I is involved in both repression and activation of transcription","volume":"6443","author":"Merino","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104266_b0025","doi-asserted-by":"crossref","first-page":"11508","DOI":"10.1073\/pnas.90.24.11508","article-title":"Identification of human DNA topoisomerase I as a cofactor for activator- dependent transcription by RNA polymerase II","volume":"24","author":"Kretzschmar","year":"1993","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0030","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1073\/pnas.85.4.1060","article-title":"Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes","volume":"4","author":"Zhang","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF00117850","article-title":"Induction of sister chromatid exchanges by inhibitors of topoisomerases","volume":"4","author":"Lim","year":"1986","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.104266_b0040","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1073\/pnas.88.22.10104","article-title":"Recombination mediated by vaccinia virus DNA topoisomerase I in Escherichia coli is sequence specific","volume":"22","author":"Shuman","year":"1991","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0045","doi-asserted-by":"crossref","first-page":"15498","DOI":"10.1016\/S0021-9258(17)40707-1","article-title":"Mammalian topoisomerase I has base mismatch nicking activity","volume":"22","author":"Yeh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0050","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/carcin\/14.9.1841","article-title":"Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair","volume":"9","author":"Stevnsner","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bioorg.2020.104266_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1054-3589(08)60542-6","article-title":"Roles of DNA topoisomerases in chromosomal replication and segregation","volume":"29A","author":"Nitiss","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104266_b0060","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1096\/fasebj.8.12.8088460","article-title":"Role of nonhistone proteins in the chromosomal events of mitosis","volume":"12","author":"Earnshaw","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2020.104266_b0065","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1083\/jcb.100.5.1716","article-title":"Localization of topoisomerase II in mitotic chromosomes","volume":"5","author":"Earnshaw","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0070","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1083\/jcb.100.5.1706","article-title":"Topoisomerase II is a structural component of mitotic chromosome scaffolds","volume":"5","author":"Earnshaw","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0075","doi-asserted-by":"crossref","unstructured":"A.D. Bates, A. Maxwell, DNA Topology, 2nd ed., Oxford University Press, Oxford, UK, 2005.","DOI":"10.1093\/oso\/9780198567097.001.0001"},{"key":"10.1016\/j.bioorg.2020.104266_b0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.embor.7400101","article-title":"A topological view of the replicon","author":"Schvartzman","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2020.104266_b0085","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/bies.1133","article-title":"Shaping the metaphase chromosome: Coordination of cohesion and condensation","volume":"10","author":"Losada","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.bioorg.2020.104266_b0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3030681","article-title":"Structure and function of type 11 DNA topoisomerases","volume":"303","author":"Paul","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2020.104266_b0095","article-title":"Untangling the double helix: DNA entanglement and the action of the DNA topoisomerases","author":"Wang","year":"2009","journal-title":"Choice Rev. Online"},{"key":"10.1016\/j.bioorg.2020.104266_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0022-2836(71)90334-2","article-title":"Interaction between DNA and an Escherichia coli protein \u03c9","volume":"3","author":"Wang","year":"1971","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0022-2836(86)90129-4","article-title":"Complete nucleotide sequence of the topA gene encoding Escherichia coli DNA topoisomerase I","volume":"3","author":"Tse-Dinh","year":"1986","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0110","doi-asserted-by":"crossref","first-page":"20532","DOI":"10.1016\/S0021-9258(19)36714-6","article-title":"Escherichia coli topoisomerase III-catalyzed cleavage of RNA","volume":"28","author":"DiGate","year":"1992","journal-title":"J. Biolog. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1365-2958.2000.01763.x","article-title":"Identification of a unique domain essential for Escherichia coli DNA topoisomerase III-catalysed decatenation of replication intermediates","volume":"4","author":"Li","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104266_b0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","article-title":"DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents","volume":"103","author":"Khan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2020.104266_b0125","article-title":"MACROMOLECULES DNA Topoisomerases","volume":"2","author":"Bush","year":"2015","journal-title":"EcoSal Plus."},{"key":"10.1016\/j.bioorg.2020.104266_b0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.str.2007.01.013","article-title":"Modular Structure of the Full-Length DNA Gyrase B Subunit Revealed by Small-Angle X-Ray Scattering","volume":"3","author":"Costenaro","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2020.104266_b0135","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/351624a0","article-title":"Crystal structure of an N-terminal fragment of the DNA gyrase B protein","volume":"6328","author":"Wigley","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104266_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","article-title":"DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities","volume":"1400","author":"Levine","year":"1998","journal-title":"Biochim et Biophysica Acta - Gene Struct. Expression"},{"key":"10.1016\/j.bioorg.2020.104266_b0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3030681","article-title":"Structure and function of type II DNA topoisomerases","volume":"303","author":"Watt","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2020.104266_b0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13543776.2019.1575362","article-title":"ATP-competitive DNA Gyrase and Topoisomerase IV Inhibitors as Antibacterial Agents","volume":"3","author":"Durcik","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.104266_b0155","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1101\/gad.838900","article-title":"Preferential relaxation of positively supercoiled DNA by E. coli topoisomerase IV in single-molecule and ensemble measurements","volume":"22","author":"Crisona","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2020.104266_b0160","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1101\/gad.872301","article-title":"Topoisomerase IV, alone, unknots DNA in E. coli","volume":"6","author":"Deibler","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2020.104266_b0165","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/nar\/gkr1237","article-title":"Topo IV is the topoisomerase that knots and unknots sister duplexes during DNA replication","volume":"8","author":"L\u00f3pez","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0170","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1101\/gad.11.19.2580","article-title":"Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli","volume":"19","author":"Zechiedrich","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2020.104266_b0175","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1073\/pnas.85.8.2543","article-title":"cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment","volume":"8","author":"D\u2019Arpa","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/367138a0","article-title":"Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I","volume":"6459","author":"Lima","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104266_b0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pharmtox.41.1.53","article-title":"Tumor cell death induced by topoisomerase-targeting drugs","volume":"41","author":"Li","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1016\/j.bioorg.2020.104266_b0190","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"5356","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.104266_b0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/364735a0","article-title":"DNA topoisomerase V is a relative of eukaryotic topoisomerase I from a hyperthermophilic prokaryote","volume":"6439","author":"Slesarev","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104266_b0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.str.2010.03.006","article-title":"Structures of Minimal Catalytic Fragments of Topoisomerase V Reveals Conformational Changes Relevant for DNA Binding","volume":"7","author":"Rajan","year":"2010","journal-title":"Structure."},{"key":"10.1016\/j.bioorg.2020.104266_b0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.emboj.7600922","article-title":"Structure of the N-terminal fragment of topoisomerase V reveals a new family of topoisomerases","volume":"2","author":"Taneja","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2020.104266_b0210","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0701989104","article-title":"Topoisomerase V relaxes supercoiled DNA by a constrained swiveling mechanism","volume":"37","author":"Taneja","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0215","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1182\/blood-2003-07-2527","article-title":"A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia","volume":"12","author":"Willmore","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2020.104266_b0220","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0092-8674(80)80046-8","article-title":"Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break","volume":"3","author":"Liu","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.104266_b0225","first-page":"3","article-title":"Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious Diseases","volume":"1","author":"Tse-Dinh","year":"2008","journal-title":"Infect Disorders - Drug Targets."},{"key":"10.1016\/j.bioorg.2020.104266_b0230","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives","volume":"3","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2020.104266_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: A review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0240","doi-asserted-by":"crossref","unstructured":"J. Davagnino, M. Herrero, D. Furlong, F. Moreno, R. Kolter, The DNA replication inhibitor microcin B17 is a forty\u2010three\u2010amino\u2010acid protein containing sixty percent glycine, Proteins: Structure, Function, and Bioinformatics. 3 (1986) 230-238. doi:10.1002\/prot.340010305.","DOI":"10.1002\/prot.340010305"},{"key":"10.1016\/j.bioorg.2020.104266_b0245","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.91.10.4519","article-title":"Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor","volume":"10","author":"Yorgey","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2020.104266_b0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-2836(92)91024-J","article-title":"Control of segregation of chromosomal DNA by sex factor F in Escherichia coli. Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition","volume":"1","author":"Miki","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0255","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-2836(92)90629-X","article-title":"Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes","volume":"3","author":"Bernard","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0260","doi-asserted-by":"crossref","first-page":"40397","DOI":"10.1074\/jbc.M110.138776","article-title":"Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors","volume":"51","author":"Yuan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.08.025","article-title":"Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity","volume":"86","author":"Yule","year":"2014","journal-title":"European J. Med. Chem.."},{"key":"10.1016\/j.bioorg.2020.104266_b0270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijmyco.2015.02.002","article-title":"Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"2","author":"Chandran","year":"2015","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.bioorg.2020.104266_b0275","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1016\/j.bmcl.2007.09.010","article-title":"N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli","volume":"23","author":"Mukherjee","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104266_b0280","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bmcl.2017.01.073","article-title":"New 1, 4-dihydro [1, 8] naphthyridine derivatives as DNA gyrase inhibitors","volume":"5","author":"Gen\u00e7er","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104266_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011013354859","article-title":"DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic","volume":"1","author":"Holden","year":"2001","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bioorg.2020.104266_b0290","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/ja00968a057","article-title":"Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata","volume":"88","author":"Wall","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.104266_b0295","doi-asserted-by":"crossref","unstructured":"C.A. Felix, Leukemias related to treatment with DNA topoisomerase II inhibitors, in: Medical and Pediatric Oncology, 5 2001 525-535. doi:10.1002\/mpo.1125.","DOI":"10.1002\/mpo.1125"},{"key":"10.1016\/j.bioorg.2020.104266_b0300","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yrtph.2006.05.004","article-title":"Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats","volume":"3","author":"Chung","year":"2006","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.bioorg.2020.104266_b0305","first-page":"2","article-title":"In vivo bioassay to detect irinotecan-stabilized DNA\/topoisomerase I complexes in rats","volume":"3","author":"Barth","year":"2009","journal-title":"Biotechnol. J. Wiley-VCH."},{"key":"10.1016\/j.bioorg.2020.104266_b0310","first-page":"7428","article-title":"Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I","volume":"21","author":"Antony","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0315","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1016\/j.bmc.2009.04.023","article-title":"Furanocoumarins: Novel topoisomerase I inhibitors from Ruta graveolens L","volume":"19","author":"Diwan","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0320","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1021\/jm200719v","article-title":"7-Azaindenoisoquinolines as topoisomerase i inhibitors and potential anticancer agents","volume":"17","author":"Kiselev","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0325","first-page":"4903","article-title":"Inhibition of Topoisomerase II by Antitumor Agents Bis(2,6-dioxopiperazine) Derivatives: Mode of Cell Growth Inhibition Distinct from that of Cleavable Complex-forming Type Inhibitors1","volume":"18","author":"Tanabe","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0330","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-291X(86)90471-7","article-title":"Mitoxantrone affects topoisomerase activities in human breast cancer cells","volume":"2","author":"Crespi","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.104266_b0335","first-page":"01","article-title":"Natural plant resources in anti-cancer therapy-A review, Research","volume":"1","author":"Nirmala","year":"2011","journal-title":"Plant Biol."},{"key":"10.1016\/j.bioorg.2020.104266_b0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.107.120865","article-title":"A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: A comparative in vivo study","volume":"2","author":"Kogan","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2020.104266_b0345","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0006-291X(76)90938-4","article-title":"Effects of the stereochemical configuration on the interaction of some daunomycin derivatives with DNA","volume":"3","author":"Zunino","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.104266_b0350","series-title":"Mechanisms of action of cancer chemo therapeutic agents: Topoisomerase inhibitors","first-page":"2","author":"Yasuhiro","year":"2002"},{"key":"10.1016\/j.bioorg.2020.104266_b0355","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1432-1033.1992.tb17275.x","article-title":"NMR study of the solution conformation of actinomycin D","volume":"1","author":"Yu","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2020.104266_b0360","series-title":"Anthracyclines and DNA Intercalators\/Epipodophyllotoxins\/DNA Topoisomerases, Cancer Medicine","author":"Eric","year":"2000"},{"key":"10.1016\/j.bioorg.2020.104266_b0365","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.toxicon.2004.05.008","article-title":"Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives","volume":"44","author":"Gordaliza","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2020.104266_b0370","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1021\/bi700272u","article-title":"Topoisomerase II-drug interaction domains: Identification of substituents on etoposide that interact with the enzyme","volume":"28","author":"Wilstermann","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104266_b0375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1477-7819-4-41","article-title":"Topoisomerase II trapping agent teniposide induces apoptosis and G2\/M or S phase arrest of oral squamous cell carcinoma","volume":"4","author":"Jinzhong","year":"2006","journal-title":"World J. Surg. Oncol.."},{"key":"10.1016\/j.bioorg.2020.104266_b0380","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1128\/jvi.62.12.4797-4800.1988","article-title":"Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome","volume":"12","author":"Benson","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104266_b0385","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/bi0021838","article-title":"DNA topoisomerase II as the target for the anticancer drug TOP-53: Mechanistic basis for drug action","volume":"3","author":"Byl","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.104266_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0010186","article-title":"Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II","volume":"5","author":"Hawtin","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2020.104266_b0395","first-page":"1275","article-title":"DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens","volume":"5","author":"van Eijk","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.104266_b0400","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.apsb.2018.07.008","article-title":"Recent developments in topoisomerase-targeted cancer chemotherapy","volume":"6","author":"Hevener","year":"2018","journal-title":"Acta Pharm. Sinica B."},{"key":"10.1016\/j.bioorg.2020.104266_b0405","doi-asserted-by":"crossref","unstructured":"(a) T. Khan, K. Sankhe, V. Suvarna, A. Sherje, K. Patel, B. Dravyakar, DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents, Biomedicine and Pharmacotherapy. 103 (2018) 923-938. doi:10.1016\/j.biopha.2018.04.021. (b) M.K. Kathiravan, M.M. Khilare, K. Nikoomanesh, A.S. Chothe, K.S. Jain, Topoisomerase as target for antibacterial and anticancer drug discovery, Journal of Enzyme Inhibition and Medicinal Chemistry. 28(3) 2013, 419-435. doi: 10.3109\/14756366.2012.658785.","DOI":"10.1016\/j.biopha.2018.04.021"},{"key":"10.1016\/j.bioorg.2020.104266_b0410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"23","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0415","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejmech.2016.10.011","article-title":"Multi-targeting exploration of new 2-aminothiazolyl quinolones: Synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells","volume":"29","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0420","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism","volume":"10","author":"Cui","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0425","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2019.06.046","article-title":"A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0430","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Fedorowicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0435","doi-asserted-by":"crossref","unstructured":"H. Govender, C. Mocktar, H.M. Kumalo, N.A. Koorbanally, Synthesis, antibacterial activity and docking studies of substituted quinolone thiosemicarbazones, Phosphorus, Sulfur and Silicon and the Related Elements. 11 (2019) 1074-1081. doi:10.1080\/10426507.2019.1618298.","DOI":"10.1080\/10426507.2019.1618298"},{"key":"10.1016\/j.bioorg.2020.104266_b0440","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1007\/s00044-013-0518-3","article-title":"In-silico design, synthesis and evaluation of novel DNA-gyrase B inhibitors","volume":"22","author":"Shiroya","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejmech.2018.10.031","article-title":"Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase","volume":"1","author":"Carta","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0450","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bmcl.2013.03.047","article-title":"Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"23","author":"Mitton-Fry","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104266_b0455","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.bmcl.2017.06.009","article-title":"Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"27","author":"Mitton-Fry","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104266_b0460","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.bmc.2015.03.004","article-title":"Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors","volume":"23","author":"Medapi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0465","doi-asserted-by":"crossref","first-page":"1900086","DOI":"10.1002\/ardp.201900086","article-title":"Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids","volume":"10","author":"Rizk","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104266_b0470","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acs.jmedchem.5b00775","article-title":"N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation","volume":"15","author":"Zidar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0475","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2016.03.079","article-title":"New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase","volume":"117","author":"Zidar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0480","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bmc.2016.10.038","article-title":"Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors","volume":"1","author":"Toma\u0161i\u010d","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0485","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cmdc.201700549","article-title":"Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors","volume":"13","author":"Durcik","year":"2017","journal-title":"Chem Med Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0490","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2018.05.011","article-title":"New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity","volume":"154","author":"Durcik","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0495","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00044-014-1245-0","article-title":"Antibacterial potential of selected 4-phenyl hydroxycoumarins: Integrated in vitro and molecular docking studies","volume":"24","author":"Veselinovi\u0107","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0500","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/molecules24152815","article-title":"Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins","volume":"15","author":"Pisano","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.104266_b0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2018.07.059","article-title":"Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity","volume":"157","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0510","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/molecules24071311","article-title":"Discovery of novel triazole-containing pyrazole ester derivatives as potential antibacterial agents","volume":"7","author":"Chu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.104266_b0515","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bioorg.2018.01.016","article-title":"Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids","volume":"77","author":"Lal","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0520","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2017.02.046","article-title":"Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors","volume":"130","author":"Jakopin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0525","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejmech.2018.07.041","article-title":"Design and synthesis of novel 1H-tetrazol-5-amine based potent antimicrobial agents: DNA topoisomerase IV and gyrase affinity evaluation supported by molecular docking studies","volume":"156","author":"Szulczyk","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0530","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1021\/jm5003028","article-title":"Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents","volume":"12","author":"Nimesh","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0535","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1039\/c3ob41953c","article-title":"Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors","volume":"6","author":"Liu","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0540","article-title":"Synthesis, Structure and Antibacterial Activity of Potent DNA Gyrase Inhibitors: N\u2032-Benzoyl-3-(4-Bromophenyl)-1H-Pyrazole-5-Carbohydrazide Derivatives","volume":"7","author":"Sun","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2020.104266_b0545","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ijms19010222","article-title":"Antibacterial evaluation and virtual screening of new thiazolyl-triazole schiff bases as potential DNA-gyrase inhibitors","volume":"1","author":"Nastas\u0103","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104266_b0550","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/j.bmc.2016.09.027","article-title":"Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents","volume":"21","author":"Li","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0555","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1021\/acs.jmedchem.5b00489","article-title":"Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site","volume":"14","author":"Tomasic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0560","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1021\/acs.jmedchem.6b00864","article-title":"Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors","volume":"19","author":"Gjorgjieva","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0565","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2015.06.027","article-title":"Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety","volume":"101","author":"Bielenica","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0570","doi-asserted-by":"crossref","unstructured":"A. Siwek, P. Staczek, M. Wujec, J. Stefa\u0144ska, U. Kosikowska, A. Malm, S. Jankowski, P. Paneth, Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides, in: Journal of Molecular Modeling, 9 (2011) 2297-2303. doi:10.1007\/s00894-010-0889-z.","DOI":"10.1007\/s00894-010-0889-z"},{"key":"10.1016\/j.bioorg.2020.104266_b0575","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.ejmech.2011.09.034","article-title":"Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides","volume":"46","author":"Siwek","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0580","first-page":"10","article-title":"Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors","volume":"1","author":"Toma\u0161i\u010d","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104266_b0585","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.bmc.2018.05.016","article-title":"Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective","volume":"26","author":"Ponnusamy","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0590","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bmc.2016.01.011","article-title":"Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"4","author":"Medapi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0595","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejmech.2016.09.053","article-title":"Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors","volume":"125","author":"Yu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0600","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4155\/fmc-2018-0472","article-title":"Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments","volume":"9","author":"Kolari\u010d","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0605","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1016\/j.bmc.2014.06.041","article-title":"Sriram, Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis","volume":"17","author":"Renuka","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0610","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acsinfecdis.8b00375","article-title":"1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition","volume":"7","author":"Li","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104266_b0615","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.04124-14","article-title":"In Vitro Antibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase\/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria","volume":"1","author":"Huband","year":"2015","journal-title":"Antimicrobial Agents Chemother."},{"key":"10.1016\/j.bioorg.2020.104266_b0620","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1016\/j.bmc.2015.08.004","article-title":"Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines","volume":"18","author":"Werner","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0625","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bmcl.2017.01.073","article-title":"New 1,4-dihydro[1,8]naphthyridine derivatives as DNA gyrase inhibitors","volume":"5","author":"Gen\u00e7er","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104266_b0630","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1007\/s00044-012-0230-8","article-title":"Synthesis, molecular modeling study, preliminary antibacterial, and antitumor evaluation of N-substituted naphthalimides and their structural analogues","volume":"22","author":"El-Azab","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104266_b0635","article-title":"Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus","volume":"20","author":"Lim","year":"2019","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:26:45Z","timestamp":1763566005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820315649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":127,"alternative-id":["S0045206820315649"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104266","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104266"}}